141 related articles for article (PubMed ID: 35248043)
1. E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter.
Liu KL; Yin YW; Lu BS; Niu YL; Wang DD; Shi B; Zhang H; Guo PY; Yang Z; Li W
Cancer Cell Int; 2022 Mar; 22(1):109. PubMed ID: 35248043
[TBL] [Abstract][Full Text] [Related]
2. Lysine demethylase 5C inhibits transcription of prefoldin subunit 5 to activate c-Myc signal transduction and colorectal cancer progression.
Yu F; Li L; Gu Y; Wang S; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Qian W; Li X; Liu Z
Mol Med; 2024 Jan; 30(1):9. PubMed ID: 38216914
[TBL] [Abstract][Full Text] [Related]
3. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of transcriptional activity of the constitutive androstane receptor (CAR) by the splicing factor SF3a3.
Yun HJ; Kwon J; Seol W
Biol Chem; 2008 Oct; 389(10):1313-8. PubMed ID: 18713018
[TBL] [Abstract][Full Text] [Related]
5. KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis.
Lin H; Ma N; Zhao L; Yang G; Cao B
Front Oncol; 2020; 10():535449. PubMed ID: 33042830
[TBL] [Abstract][Full Text] [Related]
6. Cellular stress response 1 down-regulates the expression of epidermal growth factor receptor and platelet-derived growth factor receptor through inactivation of splicing factor 3A3.
Zuo ZH; Yu YP; Martin A; Luo JH
Mol Carcinog; 2017 Feb; 56(2):315-324. PubMed ID: 27148859
[TBL] [Abstract][Full Text] [Related]
7. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.
Lin H; Yang G; Yu J; Wang J; Li Q; Guo S; Cao B
Biomed Pharmacother; 2018 Nov; 107():1205-1209. PubMed ID: 30257334
[TBL] [Abstract][Full Text] [Related]
8. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
[No Abstract] [Full Text] [Related]
9. KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma.
Zhang B; Zhou BH; Xiao M; Li H; Guo L; Wang MX; Yu SH; Ye QH
Front Oncol; 2020; 10():1025. PubMed ID: 32714863
[No Abstract] [Full Text] [Related]
10. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H
Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415
[TBL] [Abstract][Full Text] [Related]
11. KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration.
Chen X; Wang P; Ou T; Li J
Cancer Manag Res; 2022; 14():465-477. PubMed ID: 35173481
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of the X-inactivation escaping gene
Zheng Q; Li P; Zhou X; Qiang Y; Fan J; Lin Y; Chen Y; Guo J; Wang F; Xue H; Xiong J; Li F
Theranostics; 2021; 11(18):8674-8691. PubMed ID: 34522206
[No Abstract] [Full Text] [Related]
13. ADNP Upregulation Promotes Bladder Cancer Cell Proliferation
Zhu S; Xu Z; Zeng Y; Long Y; Fan G; Ding Q; Wen Y; Cao J; Dai T; Han W; Xie Y
Front Oncol; 2020; 10():491129. PubMed ID: 33240802
[TBL] [Abstract][Full Text] [Related]
14. Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression.
Ji X; Jin S; Qu X; Li K; Wang H; He H; Guo F; Dong L
BMC Cancer; 2015 Oct; 15():801. PubMed ID: 26503415
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA.
Lu BS; Yin YW; Zhang YP; Guo PY; Li W; Liu KL
Cancer Cell Int; 2019; 19():149. PubMed ID: 31164795
[TBL] [Abstract][Full Text] [Related]
16. LINC00649 promotes bladder cancer malignant progression by regulating the miR‑15a‑5p/HMGA1 axis.
Chen X; Chen S
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649788
[TBL] [Abstract][Full Text] [Related]
17. microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C.
Wang Y; Ye H; Yang Y; Li J; Cen A; Zhao L
J Endocrinol Invest; 2022 Jan; 45(1):17-28. PubMed ID: 34143366
[TBL] [Abstract][Full Text] [Related]
18. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN.
Hong Z; Wu G; Xiang ZD; Xu CD; Huang SS; Li C; Shi L; Wu DL
Biomed Pharmacother; 2019 Jun; 114():108793. PubMed ID: 30921702
[TBL] [Abstract][Full Text] [Related]
19. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
20. Elevated PSPC1 and KDM5C expression indicates poor prognosis in prostate cancer.
Lemster AL; Weingart A; Bottner J; Perner S; Sailer V; Offermann A; Kirfel J
Hum Pathol; 2023 Aug; 138():1-11. PubMed ID: 37209920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
